Adagene Management
Management criteria checks 2/4
Adagene's CEO is Peizhi Luo, appointed in Nov 2011, has a tenure of 14.08 years. directly owns 0.057% of the company’s shares, worth $47.56K. The average tenure of the management team and the board of directors is 7.2 years and 4.1 years respectively.
Key information
Peizhi Luo
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14.1yrs |
| CEO ownership | 0.06% |
| Management average tenure | 7.2yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Adagene Inc. (NASDAQ:ADAG) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Oct 10
The Consensus EPS Estimates For Adagene Inc. (NASDAQ:ADAG) Just Fell Dramatically
Oct 05Adagene ADR GAAP EPS of -$0.87 misses by $0.45, revenue of $3.93M misses by $9.82M
Aug 30Micro-cap Adagene surges after hours on $10M share buyback
Jun 29CEO
Peizhi Luo (59 yo)
Dr. Peter P. Luo, PhD, also known as Peizhi, is the Founder of Adagene Inc. and serves as its Chief Executive Officer since November 2011 and Director since February 2018. He serves as President of R&D at...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co- Founder | 14.1yrs | no data | 0.057% $ 47.6k | |
| CFO & Director | 6.3yrs | no data | no data | |
| Executive Director & Head of Human Resources | 6.2yrs | no data | no data | |
| Chief Manufacturing Officer | 5.2yrs | no data | no data | |
| Senior Vice President of Bioinformatics & Information Technology | 14.1yrs | no data | no data | |
| Senior VP & Head of Clinical Operations | 14.1yrs | no data | 0.0082% $ 6.9k | |
| Senior Vice President of Early Drug Discovery | 10.2yrs | no data | no data | |
| VP & Head of Business Development | 8.2yrs | no data | no data | |
| Executive Vice President of Clinical Development | 4.2yrs | no data | no data | |
| Senior VP of Clinical Pharmacology & Quantitative Sciences | no data | no data | no data | |
| Chief Strategy Officer | less than a year | no data | no data |
Experienced Management: ADAG's management team is seasoned and experienced (7.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co- Founder | 7.8yrs | no data | 0.057% $ 47.6k | |
| CFO & Director | 4.8yrs | no data | no data | |
| Independent Director | 2.3yrs | no data | no data | |
| Member of Scientific & Strategic Advisory Board | 4.3yrs | no data | no data | |
| Member Scientific and Strategic Advisory Board | 4.3yrs | no data | no data | |
| Independent Director | 3.1yrs | no data | no data | |
| Independent Director | 1.8yrs | no data | no data | |
| Member Scientific & Strategic Advisory Board | 3.9yrs | no data | no data | |
| Member of Scientific & Strategic Advisory Board | 1.8yrs | no data | no data | |
| Member of Scientific & Strategic Advisory Board | 2.8yrs | no data | no data | |
| Independent Director | 4.8yrs | no data | no data | |
| Member Scientific & Strategic Advisory Board | 4.3yrs | no data | no data |
Experienced Board: ADAG's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/28 17:48 |
| End of Day Share Price | 2025/12/26 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Adagene Inc. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bing Zhao | China Renaissance Securities |
| Ziyi Chen | Goldman Sachs |
| Paul Jeng | Guggenheim Securities, LLC |